Navigation Links
Trius Reports New Findings on Mechanisms of Antibiotic Resistance in MRSA
Date:9/13/2010

m Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding the potential benefits of torezolid phosphate. Risks that contribute to the uncertain nature of the forward-looking statements include: Trius' ability to obtain additional financing; the success and timing of Trius' preclinical studies and clinical trials; regulatory developments in the United States and foreign countries; the performance of third-party manufacturers; changes in Trius' plans to develop and commercialize its product candidates; Trius' ability to obtain and maintain intellectual property protection for its product candidates; and the loss of key scientific or management personnel. These and other risks and uncertainties are described more fully in Trius' most recently filed SEC documents, including its Registration Statement on Form S-1 that was originally filed with the United States Securities and Exchange Commission on November 6, 2009, and the amendments thereto, and Trius' Form 10-Q for the quarter ended June 30, 2010, including those factors discussed under the caption "Risk Factors" in such filings. All forward-looking statements contained in this press release speak only as of the date on which they were made. Trius undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

About Trius Therapeutics

Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections. The company's lead product candidate, torezolid phosphate, is an IV and orally administered second generation oxazolidinone in Phase 3 clinical development for the treatment of acute bacterial skin and skin
'/>"/>

SOURCE Trius Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Trius to Present at the Stifel Nicolaus Healthcare Conference
2. Trius Therapeutics Obtains Special Protocol Assessment With FDA for Phase 3 Study of Torezolid Phosphate
3. Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering
4. Trius Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting
5. Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections
6. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
7. Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections
8. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
9. Trius Doses First Patient in Antibacterial Phase 2 Trial
10. PacificGMP Completes GMP Product Fill for Trius Therapeutics
11. Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... /CNW/ - Sante Medical Hair Restoration is now offering ... The ARTAS Robotic System is a ... hair for transplantation. This latest development in minimally-invasive ... no linear scar. "The ARTAS technology ... restoration surgery." says Dr. Louis Grondin , ...
(Date:3/3/2015)... Registration is officially open for MEDTEC China South 2015, which ... Convention & Exhibition Center. The Shenzhen ... MEDTEC China family of events. MEDTEC China South, an exhibition ... the South China market through staging ... for China,s medical device industry. This ...
(Date:3/3/2015)... 3, 2015  RedHill Biopharma Ltd. (NASDAQ/TASE: ... biopharmaceutical company primarily focused on late clinical-stage, ... diseases, including gastrointestinal cancers, today announced that ... Officer, will be presenting at VirtualInvestorConferences.com, a ... March 5, 2015, at 10:00 am EST. ...
Breaking Medicine Technology:No linear scar. Permanent results. 2Pre-registration Open for 2015 MEDTEC China South 2Pre-registration Open for 2015 MEDTEC China South 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 2RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 4
(Date:3/4/2015)... Ada Products Company, Inc ., an ... strategic partnership with the Dental Exchange in an effort ... them to engaging, inspiring ideas, products, career opportunities, and ... Dental Exchange is a first-of-its kind online resource ... other social platforms, the Dental Exchange dives much deeper ...
(Date:3/4/2015)... Jose, California (PRWEB) March 04, 2015 ... Surgical endoscopy is witnessing strong growth worldwide, supported ... The development of robot-assisted surgery and single incision ... market. Major benefits of minimally invasive surgery, driving ... reduced trauma to the surgical site, lower blood ...
(Date:3/4/2015)... Bird B Gone, the leader in bird ... offers its popular plastic (polycarbonate) bird spike in seven ... bird deterrent is ready-to-use and comes in a ... of the building or structure onto which it is ... light grey, brown, black and tan—make the spikes virtually ...
(Date:3/4/2015)... Texas (PRWEB) March 04, 2015 ... today announced that Alan Daugherty has been named ... immediately. Daugherty has served as interim CEO of ... , “Alan has provided tremendous leadership during his ... abilities leading hospital strategy and developing relationships with ...
(Date:3/3/2015)... Anik Singal's Profit Academy - ... marketers has become the talk of the town ... surrounding the course's general release has garnered the ... her to review the program's content and publish ... biggest keys to success with Internet marketing is ...
Breaking Medicine News(10 mins):Health News:Ada Products Company, Inc. Announces Strategic Partnership with the Dental Exchange 2Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Plastic Bird Spikes Now Come in 7 Colors to Blend in With Their Surroundings 2Health News:Alan Daugherty Named CEO of Parkview Regional Hospital and Ennis Regional Medical Center 2Health News:Alan Daugherty Named CEO of Parkview Regional Hospital and Ennis Regional Medical Center 3Health News:Anik Singal's Profit Academy - Review Of New IM Training Program Released 2
... arteries, veins and capillaries become diseased, patients can experience ... stroke and heart attack.// Dennis Gable, M.D., a vascular ... Center at Plano, provides information about three of the ... ,Varicose veins are large, twisted, swollen blood vessels that ...
... The University of Pennsylvania School of Medicine has isolated a ... to differentiate into several cell types.// If the cells ... are grown in increased magnitude, then it is possible to ... of disorders that includes peripheral nerve disease, Parkinson's disease, and ...
... Dr. Matt Messina, consumer advisor to the American Dental Association, ... a nice 'bling' to a smile but they// could also ... explained that removable dental fixtures like the 'grills' or 'fronts' ... very happening trends among he younger so called 'hip-hop' generations. ...
... has launched National Transplant Week to raise awareness of the ... place and the number of people// awaiting transplants. ... in Britain has joined the Organ Donor Register. In addition ... transplant lists, only 2,200 actually operations took place. ...
... test results of women in north Queensland have been reviewed ... ,According to the Queensland Health Minister Stephen Robertson there was ... area in recent months. ,9,300 cases were reviewed. ... for further testing and two showed non-malignant cancers. ...
... technique of positron emission tomography (PET) have been able to ... chemistry// and the susceptibility of an individual to resort to ... ,The research, in animals, shows a significant correlation ... for the neurotransmitter dopamine – measured before cocaine use begins ...
Cached Medicine News:Health News:Vascular Disease 101: Discovering and Treating Common Diseases of the Veins 2Health News:Varied Applications of Adult Stem Cells to Treat Host of Disorders in Human 2Health News:Dental Grills harmful For Users 2Health News:National Transplant Week to Raise Need for Organ Donation 2Health News:Definite Connection Between Receptor Levels and Cocaine Abuse Reveals PET Imaging 2Health News:Definite Connection Between Receptor Levels and Cocaine Abuse Reveals PET Imaging 3
The Radionics XKnife RT2 system provides a precise and versatile stereotactic radiation therapy solution....
The Primus linear accelerator is a fully digital, technologically advanced radiation therapy treatment delivery system. It can be configured for delivery of routine, 3-D conformal or IMRT treatments....
Clinac EX Platinum accelerators offer all the high performance features of the EX series and come standard with the latest high-precision dose sculpting technology for advanced tumor control....
... cost-effective, proven and reliable system. Varian ... rapid patient treatment, fastest beam-on times ... less than 500 milliseconds, pulse-to-pulse beam ... stability, greatest number of multileaf collimator ...
Medicine Products: